Skip to main content
. 2015 Apr 16;350:h1618. doi: 10.1136/bmj.h1618

graphic file with name nave024651.f5_default.jpg

Fig 5 Individual and summary odds ratios for the endpoint of repeat revascularisation. Data stratified by duration of dual antiplatelet therapy: short term (<12 months) versus 12 months, and extended (>12 months) versus 12 months